Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jan 07, 2026

SELL
$5.64 - $8.0 $1,364 - $1,936
-242 Closed
0 $0
Q1 2025

Jan 07, 2026

BUY
$8.16 - $9.85 $1,974 - $2,383
242 New
242 $1.98 Million
Q4 2024

Jan 07, 2026

BUY
$9.36 - $12.01 $2,265 - $2,906
242 New
242 $2.28 Million

Others Institutions Holding FOLD

About AMICUS THERAPEUTICS, INC.


  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Aventura Private Wealth, LLC Portfolio

Follow Aventura Private Wealth, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aventura Private Wealth, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aventura Private Wealth, LLC with notifications on news.